The largest database of trusted experimental protocols

185 protocols using insulin

1

Insulin-Induced Akt Phosphorylation Kinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the detection of insulin-induced Akt phosphorylation, 62.5 mU/kg insulin (Eli Lilly, Indianapolis, IN, USA) was administered through the vena cava, and liver, perigonadal fat, inguinal fat, and skeletal muscle were harvested at 5, 8, 10, and 15 min after insulin infusion. The harvested tissues were frozen immediately by liquid nitrogen and stored at −80 °C.
+ Open protocol
+ Expand
2

Investigating Vascular Regulation Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stimulated vasodilation was assessed after pretreatment with DMSO (control), wortmannin to inhibit phosphatidylinositol 3-kinase (PI3K) or Nω-nitro-L-arginine (LNNA), an NO synthase (NOS) inhibitor. Systolic arterial blood pressure was measured to check the increase in blood pressure caused by LNNA, a specific NOS inhibitor (20 mg kg−1; ip) [28 (link)]. For wortmannin injection (in 4% DMSO; 16 µg kg−1; ip), the protocol was conducted as described above after a resting period of 15 min [29 (link)]. Indomethacin (5 mg kg−1; i.p.), was used as a non-specific inhibitor of cyclooxygenases (COX) [30 (link), 31 (link)] while specific inhibition of inducible COX-2 (Cayman Chemicals, MI, USA) was achieved with SC-58125 (10 mg kg−1; i.v.) [32 (link)]. The role of insulin and adiponectin in PIV was assessed by either a single ip injection of insulin (0.05 UI 25−1 g of mouse body weight; Lilly, Suresnes, France) or a single intradermic injection of adiponectin (50 µg.mL-1; Enzo LifeSciences, Farmingdale, NY). Assessment of PIV was conducted 15 min after insulin injection and immediately after adiponectin injection.
At the end of vascular experiments, the animals were euthanized by an overdose of thiopental.
+ Open protocol
+ Expand
3

Glucose and Insulin Tolerance Tests

Check if the same lab product or an alternative is used in the 5 most similar protocols
For glucose tolerance test, mice were intraperitoneally injected with glucose at 2 g per kg body weight after 12 h of fasting. For insulin tolerance test, mice were intraperitoneally injected with insulin (Eli Lilly and Company, Indianapolis, IN, USA) at 1 IU per kg body weight after 6 h of fasting. In all tests, tail blood glucose levels were measured with a glucometer (Abbott, Chicago, IL, USA) at the indicated times (0, 30, 60, 90, 120 and 180 min) after injection.
+ Open protocol
+ Expand
4

Optimized Stem Cell Culture Media

Check if the same lab product or an alternative is used in the 5 most similar protocols
Basal medium consisted of Dulbecco’s modified Eagle’s medium-high glucose (Sigma-Aldrich, USA) supplemented with 5 mM sodium bicarbonate (Cinética Química Ltda, Brazil), penicillin (100 units/mL; Sigma-Aldrich), streptomycin (0.1 mg/mL; Sigma-Aldrich), amphotericyn B (0.25 μg/mL; Sigma-Aldrich), gentamicin (60 mg/L; Schering-Plough, USA), and 10% of either aHS or FBS (Cripion Biotecnologia Ltda, Brazil). Adipogenic medium consisted of basal medium with 0.5 mM isobutylmethylxanthine (Sigma-Aldrich), 200 μM indomethacin (Sigma-Aldrich), 1 μM dexamethasone (Aché, Brazil), and 10 μM insulin (Eli Lilly and Company, USA). Osteogenic medium consisted of basal medium with 50 μg/mL ascorbate-2-phosphate (Ecibra, Brazil), 10 mM β-glycerophosphate (Sigma-Aldrich), and 0.1 μM dexamethasone (Aché). Chondrogenic medium consisted of basal medium with 1 mM dexamethasone (Aché), 125 μg/mL bovine serum albumin (PAA, Austria), 1 mM pyruvate (Sigma-Aldrich), 200 U/mL insulin (Eli Lilly and Company), 3.25 μg/mL transferrin (Wako, Brazil), 0.01 μg/mL transforming growth factor-β1 (Sigma-Aldrich), 5 mg/mL ascorbate-2-phosphate (Ecibra) and a reduced concentration of serum supplements - 1% aHS or 1% FBS [5 (link)].
+ Open protocol
+ Expand
5

Differentiation of 3T3-L1 Adipocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
3T3-L1 cells were cultured in high-glucose DMEM supplemented with 100 U of penicillin/mL, 100 μg of streptomycin/mL, and 10% FBS in 5% CO2, 37°C incubator. The cells were allowed to grow for 2 more days after 100% confluency was reached; then, the cells were differentiated through the addition of differentiate medium (complete medium supplemented with 500 μM isobutylmethylxanthine (Sigma-Aldrich Co., St. Louis, USA), 25 μM dexamethasone (Sigma-Aldrich Co., St. Louis, USA), and 4 μg/mL insulin (Eli Lilly and Company, Indianapolis, USA)) for 3 days and then complete medium with 4 μg/mL insulin was added for an additional 3 days. The differentiated cells were maintained in complete medium for 6 additional days till the cells were fully differentiated.
+ Open protocol
+ Expand
6

Culturing Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human MCF7, T47D, and MDA-MB-231 BC cell lines were purchased from American Type Culture Collection (Manassas, VA). Human SUM159PT BC cell lines were purchased from Asterand (Detroit, MI). SUM159PT-ZsGreen-cODC, MCF7-ZsGreen-cODC, T47D-ZsGreen-cODC, and MDA-MB-231-ZsGreen-cODC were obtained as described by Vlashi et al.7 (link) SUM159PT cells were cultured in log-growth phase in F12 Medium (Invitrogen, Carlsbad, CA) supplemented with 5% fetal bovine serum (Sigma-Aldrich, St. Louis, MO) and penicillin (100 units/mL) and streptomycin (100 μg/mL) cocktail (Invitrogen), 5 μg/mL insulin (Eli Lilly, Indianapolis, IN), 0.5% 1M hydroxyethyl piperazineethanesulfonic acid (Invitrogen), and 1 μg/mL hydrocortisone (Pfizer, New York, NY). T47D and MDA-MD-231 cells were cultured in log-growth phase in Dulbecco’s Modified Eagle Medium (Invitrogen) supplemented with 10% fetal bovine serum and penicillin (100 U/mL) and streptomycin (100 μg/mL) cocktail. MCF7 cells were cultured in log-growth phase in Minimum Essential Media Alpha (Invitrogen) supplemented with 10% fetal bovine serum and penicillin (100 U/mL) and streptomycin (100 μg/mL) cocktail, nonessential amino acids (1 ×; NEAA, Invitrogen), 1 mM sodium pyruvate (Invitrogen), and 5 μg/mL insulin (Eli Lilly). All cells were grown in a humidified incubator at 37°C with 5% CO2.
+ Open protocol
+ Expand
7

Glucose and Insulin Tolerance Tests in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commencing at 0800 h, mice were fasted either 6 h prior to IPGTT or 4 h prior to IPITT, then injected with glucose (1 g·kg−1 total lean mass; Sigma-Aldrich, St. Louis, MO, USA) or insulin (0.5 U·kg−1 total body mass; Humulin, Eli Lilly and Company, Indianapolis, IN, USA), respectively. Blood glucose was monitored via tail tip bleed using a glucometer (Accu-Check Performa, Roche Diagnostics GmbH, Mannheim, Germany). Mice were allowed at least one week of recovery between tests.
+ Open protocol
+ Expand
8

Glucose and Insulin Tolerance in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glucose Tolerance Test: Mice were fasted for 16 h before an intraperitoneal (IP) injection d-glucose (2 g/kg body WT; Sigma, St. Louis, MO) was administered 4 h after onset of the light cycle, and glucose was measured at 0, 10, 20, 30, 60, 90, and 120 min after the injection.
insulin Tolerance Test: Ad libitum-fed-mice were injected IP with insulin (0.75 U/kg; Lilly, Indianapolis, IN) 8 h after onset of the light cycle and glucose was measured at 0, 20, 40, 60, 80, 100, 120, and 140 min after the injection.
Glucose levels for both tests were measured using a OneTouch Ultra glucometer (Lifescan, Milpitas, CA).
+ Open protocol
+ Expand
9

Glucose and Insulin Tolerance Tests

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glucose tolerance test (GTT) was performed by administrating glucose (2.0 mg/g BW) intraperitoneally after a 16-hour fast. Blood glucose levels were monitored using glucose test strips and a glucometer (OneTouch ultra, LifeScan) at indicated times. Blood was also collected from tails using EDTA-treated microcapillaries and plasma insulin levels were measured using an EIA kit (ALPCO). For insulin tolerance test (ITT), mice were fasted for 4 hours and injected insulin (1.0 mU/g BW, Lilly) intraperitoneally, and blood glucose levels were measured at indicated times.
+ Open protocol
+ Expand
10

Insulin-Stimulated AKT Phosphorylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
24-hour fasted mice were i.p. injected with insulin (5 mU/g BW, Lilly) or PBS as vehicle control. 15 minutes later, mice were euthanized and skeletal muscle and fat samples were dissected. Samples were then subjected to western blot analysis using rabbit anti-phospho AKT (Ser473) and rabbit anti-pan AKT monoclonal antibodies (4060 and 4691, Cell Signaling).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!